SecBot SecBot

Seniors’ Access to Critical Medications Act of 2025

H.R. 2484 Rep. Diana Harshbarger (R-TN-1) In committee
Bill text PDF
  1. Introduced Mar 31
  2. Committee Mar 31
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Mar 31, 2025Next: House vote
546d ago Apr 29, 2025: Ordered to be Reported by the Yeas and Nays: 38 - 7.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
5companies, 23 filings
Subscribe to see spend
Member trades
13trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

5 companies
Companies by sector
Biotech & Pharma 2Medical Devices & Healthcare 2Consumer & Retail 1
Search all 5 companies, their asks and price moves Subscribe

Summary

Seniors’ Access to Critical Medications Act of 2025

Full summary3 paragraphs

This bill temporarily expands flexibilities under the Stark law (i.e., the Physician Self-Referral Law) for certain physicians who dispense covered outpatient drugs under the Medicare prescription drug benefit at the physician's office location (e.g., through an integrated pharmacy). The Stark law generally prohibits physicians from referring patients to receive services that are payable under Medicare or Medicaid from entities in which the physician or an immediate family member has a financial relationship.

Specifically, the bill allows, from 2026-2030, physicians to dispense such drugs from the physician's office, including through in-person pickup by a caregiver or via mail, if (1) the physician prescribed the drug, (2) the beneficiary has an ongoing relationship with the physician, (3) the beneficiary had at least one face-to-face visit with the physician in the prior year, and (4) the physician bills for the drug. These requirements also apply to physicians within the same group practice.

The Government Accountability Office must report on pharmacies or pharmacy networks that dispense significantly more covered drugs under the Medicare prescription drug benefit after the bill's enactment, the extent to which such pharmacies and networks are owned by physicians or integrated into physician practices, and the common characteristics of these types of arrangements.

Library of Congress summary, Mar 31, 2025

Summary versions
  • Introduced in HouseMar 31, 2025

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.